Table 5.
Week from randomization | α-Lipoic acid treatment | α-Lipoic acid withdrawal |
---|---|---|
Week 4 | (i) Ibuprofen (1) (ii) Ketorolac (1) |
(i) Amitriptyline (1) (ii) Ketorolac (2) |
| ||
Week 8 | (i) Amitriptyline (1) (ii) Ibuprofen (1) (iii) Ketorolac (2) |
(i) Amitriptyline (1) (ii) Tramadol (1) (iii) Dextropropoxyphene (1) (iv) Gabapentin (2) (v) Diclofenac (1) |
| ||
Week 12 | (i) Tramadol (1) (ii) Dextropropoxyphene (1) (iii) Ibuprofen (1) |
(i) Amitriptyline (2) (ii) Diclofenac plus vitamin B (2) (iii) Meloxicam (2) (iv) Gabapentin (2) |
| ||
Week 16 | (i) Tramadol (1) (ii) Naproxen (1) (iii) Paracetamol (1) (iv) Ibuprofen (1) |
(i) Amitriptyline (2) (ii) Diclofenac plus vitamin B (2) (iii) Meloxicam (2) (iv) Gabapentin (2) |